Vol. 29 No. 4 (2025): Patologiya krovoobrashcheniya i kardiokhirurgiya
EXPERIMENTAL STUDIES

Preclinical study of the efficacy of the VVF34 composition for chemical myocardial ablation

pdf (Русский)
  • David S. Sergeevichev,
  • Anna A. Dokuchaeva,
  • Vladislav V. Fomenko,
  • Elena V. Chepeleva,
  • Dmitry A. Astapov
David S. Sergeevichev
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Anna A. Dokuchaeva
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Vladislav V. Fomenko
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Elena V. Chepeleva
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Dmitry A. Astapov
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
DOI: https://doi.org/10.21688/1681-3472-2025-4-6-12

Published 2026-01-21

Keywords

  • ethanol ablation; intramyocardial injection; preclinical study; ventricular arrhythmia

How to Cite

Sergeevichev, D. S. S., Dokuchaeva, A. A. D., Fomenko, V. V. F., Chepeleva, E. V. C., & Astapov, D. A. A. (2026). Preclinical study of the efficacy of the VVF34 composition for chemical myocardial ablation. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 29(4), 6–12. https://doi.org/10.21688/1681-3472-2025-4-6-12

Copyright (c) 2026 Давид Сергеевичев, Анна Андреевна Докучаева, Владислав Викторович Фоменко, Елена Васильевна Чепелева, Дмитрий Александрович Астапов

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Background: Ventricular arrhythmias (VA) remain a leading cause of cardiovascular mortality. Existing ablation methods, including radiofrequency ablation (RFA), have limitations related to the depth and homogeneity of the lesion created.

Objective: The objective of this study was to experimentally assess the efficacy of a new method on controlled chemical myocardial ablation using the VVF34 composition.

Methods: The study was conducted on rats (n = 60) and minipigs (n = 6). The histological dynamics and dose-dependent fibrosis formation in response to intramuscular administration of VVF34 (0.1; 0.2 and 0.3 ml) were studied in rats. Intramyocardial injection under fluoroscopic guidance using a Myostar catheter was tested in minipigs, and the safety of the procedure was assessed using echocardiography and electrocardiography.

Results: VVF34 has been shown to induce dose-dependent formation of a sharply marginated zone. A low dose (0.1 ml) proved to be optimal, resulting in the formation of dense fibrosis with minimal inflammation, while elevating the dose caused destructive necrosis. To create extended ablation lines, it was appropriate to use a series of injections spaced at least 3 mm. The intramyocardial injection procedure was safe, did not have a proarrhythmic effect, and did not impair cardiac contractility.

Conclusion: Chemical ablation with VVF34 composition is a promising alternative to existing approaches and enables to create controlled homogeneous deep fibrotic lesions, opening up new possibilities for the treatment of resistant ventricular arrhythmias.

pdf (Русский)

References

  1. Everson-Rose S.A., Roetker N.S., Lutsey P.L., Kershaw K.N., Longstreth W.T. Jr, Sacco R.L., Diez Roux A.V., Alonso A. Chronic stress, depressive symptoms, anger, hostility, and risk of stroke and transient ischemic attack in the multi-ethnic study of atherosclerosis. Stroke. 2014;45(8):2318-23. PMID: 25013018; PMCID: PMC4131200. https://doi.org/10.1161/STROKEAHA.114.004815
  2. Kudaiberdieva G., Gorenek B. Cost-Effectiveness of Atrial Fibrillation Ablation. J Atr Fibrillation. 2013;6(1):880. PMID: 28496862; PMCID: PMC5153071. https://doi.org/10.4022/jafib.880
  3. Dorn L., Kranzburg A., Saumell A., Gregory T., Reich S. Radiofrequency catheter ablation for atrial fibrillation. JAAPA. 2015;28(5):40-5. PMID: 25909541. https://doi.org/10.1097/01.JAA.0000464275.36493.2d
  4. Kalla M., Sanders P., Kalman J.M., Lee G. Radiofrequency Catheter Ablation For Atrial Fibrillation: Approaches And Outcomes. Heart Lung Circ. 2017;26(9):941-949. PMID: 28697936. https://doi.org/10.1016/j.hlc.2017.05.125
  5. Lin H., Chen Y.H., Hou J.W., Lu Z.Y., Xiang Y., Li Y.G. Role of contact force-guided radiofrequency catheter ablation for treatment of atrial fibrillation: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28(9):994-1005. PMID: 28569422. https://doi.org/10.1111/jce.13264
  6. Sathyamurthy I., Nayak R., Oomman A., Subramanyan K., Kalarical M.S., Mao R., Ramachandran P. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy – 8 years follow up. Indian Heart J. 2014;66(1):57-63. PMID: 24581097; PMCID: PMC5125590. https://doi.org/10.1016/j.ihj.2013.12.008
  7. Bonaventura J., Norambuena P., Votýpka P., Hnátová H., Adlová R., Macek M. Jr, Veselka J. Patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation have favorable long-term outcome irrespective of their genetic background. Cardiovasc Diagn Ther. 2020;10(2):193-200. PMID: 32420099; PMCID: PMC7225433. https://doi.org/10.21037/cdt.2020.01.12
  8. Сергеевичев Д.С., Романов А.Б., Фоменко В.В., Салахутди- нов Н.Ф. «Композиция для химической аблации тканей и ее применение». Патент RU 2791906 от 30.12.2022. Sergeevichev D.S., Romanov A.B., Fomenko V.V., Salakhutdinov N.F. “Composition for chemical ablation of tissues and its application”. Patent RU 2791906, 30.12.2022. (In Russ.)
  9. Руководство по проведению доклинических исследований лекарственных средств. Часть первая. М.: Гриф и К, 2012. 944 с. Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv. Chast pervaya. M.: Grif i K, 2012. 944 s. (In Russ.)
  10. Bhaskaran A., Tung R., Stevenson W.G., Kumar S. Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches. Heart Lung Circ. 2019;28(1):84-101. PMID: 30385114. https://doi.org/10.1016/j.hlc.2018.10.007
  11. Schurmann P., Peñalver J., Valderrábano M. Ethanol for the treatment of cardiac arrhythmias. Curr Opin Cardiol. 2015;30(4):333-43. PMID: 26049378; PMCID: PMC4524564. https://doi.org/10.1097/HCO.0000000000000183
  12. Callans D.J., Ren J.F., Narula N., Patel V., Michele J., Gelzer A., Dillon S.M. Left ventricular catheter ablation using direct, intramural ethanol injection in swine. J Interv Card Electrophysiol. 2002;6(3):225-31. PMID: 12154324. https://doi.org/10.1023/a:1019505703083
  13. Flautt T., Valderrábano M. Chemical Ablation of Ventricular Tachycardia Using Coronary Arterial and Venous Systems. Card Electrophysiol Clin. 2022;14(4):743-756. PMID: 36396190. https://doi.org/10.1016/j.ccep.2022.08.002
  14. Каштанов М.Г., Чернышев С.Д., Кардапольцев Л.В., Бердников С.В., Идов Э.М. Три ахиллесовы пяты этаноловой септальной аблации. Патология кровообращения и кардиохирургия. 2017;21(3):12-22. http://dx.doi.org/10.21688/1681-3472-2017-3-12-22 Kashtanov M.G., Chernyshev S.D., Kardapoltsev L.V., Berdnikov S.V., Idov E.M. Three Achilles’ heels of alcohol septal ablation. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2017;21(3):12-22. (In Russ.) http://dx.doi.org/10.21688/1681-3472-2017-3-12-22